Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to glucagon-like peptide-1 (GLP-1). Studies suggest that this peptide may ...

GLP-1 RAs represent new obesity medications that include semaglutide together with the older medication liraglutide and the recently authorised tirzepatide, a dual GLP-1/GIP RAs agonist.

National Synchrotron Radiation Laboratory, CAS Center for Excellence in Nanoscience, University of Science and Technology of China, Hefei 230029, P. R. China National Synchrotron Radiation Laboratory, ...

The World Health Organization (WHO) reports that more than 40% of adults worldwide are overweight or obese — a statistic that has nearly tripled since 1975. 1,2 However, sustainable weight loss ...

Ozempic, Wegovy sales have soared in recent years Shortages and insurance coverage have made it difficult to get The naturally occurring molecule shows promise in suppressing appetite Ozempic ...

The goal is to determine how often this lincRNA molecule is activated in these cancers. They also hope to identify whether these RNA molecules are more common in any particular tumor subgroups ...

The device, dubbed NPM-115, is a miniature sub-dermal implant that delivers exenatide, a glucagon-like peptide-1 receptor agonist (GLP-1RA). Image credit: Shutterstock / Formatoriginal. A day after ...

(NewsNation) — Researchers at Stanford Medicine have discovered a naturally occurring molecule they believe is similar to the active ingredient in the same diabetes drugs that have shown weight loss ...

The immune molecule TGFβ has been found to weaken immune defences against latent viruses, triggering reactivation of the Epstein–Barr virus. This mechanism links TGFβ release in SARS-CoV-2 ...

Department of Pharmacology and Chemical Biology, Institute of Molecular Medicine, Collaborative Innovation Center for Clinical and Translational Science by Chinese Ministry of Education & Shanghai, ...

This review presented fundamental information regarding two categories of GLP-1 receptor agonists (GLP-1RAs): peptide-based and small molecule compounds, and elaborated their potential neuroprotective ...